Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Alaunos Therapeutics Inc (TCRT)

Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study GlobeNewswire - Mon Jun 29, 7:35AM CDT

This statistical finding supports a lower liver-weight signal after adjustment for body fat percentage, suggesting the finding was not fully explained by measured body fat in this model Liver-weight...

TCRT : 1.9400 (+1.04%)
Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies GlobeNewswire - Tue May 26, 10:01AM CDT

ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, including reductions in body weight and fat mass, improved insulin sensitivity, enhanced adipose function, and...

TCRT : 1.9400 (+1.04%)
Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models GlobeNewswire - Mon May 18, 7:00AM CDT

FORT LAUDERDALE, Fla., May 18, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT)  today announced updated preclinical data from non-GLP diet-induced obesity (DIO) mouse studies evaluating...

TCRT : 1.9400 (+1.04%)
Ziopharm: Q1 Earnings Snapshot AP - Fri May 15, 4:36PM CDT

Ziopharm: Q1 Earnings Snapshot

TCRT : 1.9400 (+1.04%)
Valion Bio Appoints Melinda Lackey as General Counsel PR Newswire - Mon May 4, 3:05PM CDT

Seasoned Biopharmaceutical Attorney with Deep IP, Clinical-Stage, and Nasdaq Public Company Experience Joins Leadership Team

TCRT : 1.9400 (+1.04%)
VBIO : 0.2970 (+3.85%)
Ziopharm: Q4 Earnings Snapshot AP - Tue Mar 31, 5:47PM CDT

Ziopharm: Q4 Earnings Snapshot

TCRT : 1.9400 (+1.04%)
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders GlobeNewswire - Mon Mar 2, 5:30AM CST

The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse model ALN1003 also demonstrated reductions in liver weight and improvements...

TCRT : 1.9400 (+1.04%)
Ziopharm: Q3 Earnings Snapshot AP - Fri Nov 14, 2025

Ziopharm: Q3 Earnings Snapshot

TCRT : 1.9400 (+1.04%)
Ziopharm: Q2 Earnings Snapshot AP - Thu Aug 14, 2025

Ziopharm: Q2 Earnings Snapshot

TCRT : 1.9400 (+1.04%)
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering GlobeNewswire - Mon Jun 23, 2025

TCRT : 1.9400 (+1.04%)

Barchart Exclusives

Texas Instruments vs. Qualcomm: One Pays Out 94% of Earnings. The Better Dividend Chip Stock Is Clear. Barchart - 1 hour ago
Texas Instruments and Qualcomm offer different paths to AI growth and dividend income, but which chip stock gives investors the better setup? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.